skip to navigation skip to content
Search

In the media

 

Business Weekly: Cambridge startup raises $103m in first close of Series B

Bit.bio company that combines synthetic and stem cell biology, has raised £103 in Serie B round. Founder and CEO Dr Mark Kotter said: “I’m thrilled that bit.bio is supported by world class investors and strategic partners. The capital will enable us to accelerate our clinical and commercial scale-up and to deliver cell therapies for every patient, everywhere.”

Bit.bio was previously on Accelerate Cambridge programme run by Cambridge Judge’s Entrepreneurship Centre.

Read the full article [businessweekly.co.uk]